{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:00:11Z","timestamp":1789545611022,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10549-018-4840-9","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T03:19:14Z","timestamp":1528168754000},"page":"461-469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Extent of regional lymph node surgery and impact on outcomes in patients with early-stage breast cancer and limited axillary disease undergoing mastectomy"],"prefix":"10.1007","volume":"171","author":[{"given":"Omar","family":"Picado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Khazeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Yakoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Avisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan B.","family":"Kesmodel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"issue":"10","key":"4840_CR1","doi-asserted-by":"publisher","first-page":"e430e41","DOI":"10.1016\/S1470-2045(16)30311-4","volume":"17","author":"I Jatoi","year":"2016","unstructured":"Jatoi I, Benson JR, Toi M (2016) De-escalation of axillary surgery in early breast cancer. Lancet Oncol 17(10):e430\u2013e41","journal-title":"Lancet Oncol"},{"issue":"6","key":"4840_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman K, Beitsch P, Whitworth PW, Blumencranz P et al (2011) Sentinel lymph node dissection with and without axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569\u2013575","journal-title":"JAMA"},{"issue":"1","key":"4840_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jamcollsurg.2015.02.035","volume":"221","author":"K Yao","year":"2015","unstructured":"Yao K, Liederbach E, Pesce C, Wang C, Winchester DJ (2015) Impact of the American College of Surgeons Oncology Group Z0011 randomized trial on the number of axillary nodes removed for patients with early-stage breast cancer. J Am Coll Surg 221(1):71\u201381","journal-title":"J Am Coll Surg"},{"issue":"10","key":"4840_CR4","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1245\/s10434-012-2531-z","volume":"19","author":"AS Caudle","year":"2012","unstructured":"Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A et al (2012) American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns. Ann Surg Oncol 19(10):3144\u20133151","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"4840_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 14(4):297\u2013305","journal-title":"Lancet Oncol"},{"issue":"12","key":"4840_CR6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE et al (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15(12):1303\u20131310","journal-title":"Lancet Oncol"},{"issue":"3","key":"4840_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","volume":"15","author":"KY Bilimoria","year":"2008","unstructured":"Bilimoria KY, Stewart AK, Winchester DP, Ko CY (2008) The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 15(3):683\u2013690","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"4840_CR8","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1245\/s10434-017-6075-0","volume":"24","author":"CT Ong","year":"2017","unstructured":"Ong CT, Thomas SM, Blitzblau RC, Fayanju OM, Park TS, Plichta JK et al (2017) Patient age and tumor subtype predict the extent of Axillary Surgery among breast cancer patients eligible for the American College of Surgeons Oncology Group Trial Z0011. Ann Surg Oncol 24(12):3559\u20133566","journal-title":"Ann Surg Oncol"},{"key":"4840_CR9","unstructured":"NCDB PUF (2015) Data Dictionary. http:\/\/ncdbpuf.facs.org\/node\/259"},{"key":"4840_CR10","unstructured":"United States Census Bureau GD. Census Regions and Divisions of the United States. https:\/\/www2.census.gov\/geo\/pdfs\/maps-data\/maps\/reference\/us_regdiv.pdf"},{"key":"4840_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"4840_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2307\/1402659","volume":"43","author":"NE Breslow","year":"1975","unstructured":"Breslow NE (1975) Analysis of survival data under the proportional hazards model. Int Stat Rev 43(1):45\u201357","journal-title":"Int Stat Rev"},{"key":"4840_CR13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"D Cox","year":"1972","unstructured":"Cox D (1972) Regression models and life tables. J R Stat Soc 34:187\u2013220","journal-title":"J R Stat Soc"},{"issue":"1","key":"4840_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/SLA.0b013e318153ff40","volume":"247","author":"L Bergkvist","year":"2008","unstructured":"Bergkvist L, de Boniface J, Jonsson PE, Ingvar C, Liljegren G, Frisell J et al (2008) Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study. Ann Surg 247(1):150\u2013156","journal-title":"Ann Surg"},{"issue":"3","key":"4840_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P et al (2016) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Ann Surg 264(3):413\u2013420","journal-title":"Ann Surg"},{"issue":"13","key":"4840_CR16","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1200\/JCO.2000.18.13.2553","volume":"18","author":"AE Giuliano","year":"2000","unstructured":"Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W et al (2000) Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18(13):2553\u20132559","journal-title":"J Clin Oncol"},{"issue":"6","key":"4840_CR17","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546\u2013553","journal-title":"N Engl J Med"},{"issue":"10","key":"4840_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927\u2013933","journal-title":"Lancet Oncol"},{"issue":"10","key":"4840_CR19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR et al (2017) Effect of axillary dissection versus no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA 318(10):918\u2013926","journal-title":"JAMA"},{"issue":"6","key":"4840_CR20","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.amjsurg.2014.08.009","volume":"208","author":"K Robinson","year":"2014","unstructured":"Robinson K, Pockaj BA, Wasif N, Kaufman K, Gray (2014) Richard. Have the American College of Surgeons Oncology Group Z0011 trial results inluenced the number of lymph nodes removed during sentinel lymph node dissection? Am J Surg 208(6):1060\u20131064","journal-title":"Am J Surg"},{"issue":"3","key":"4840_CR21","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1245\/s10434-016-5605-5","volume":"24","author":"E FitzSullivan","year":"2017","unstructured":"FitzSullivan E, Bassett RL, Kuerer HM, Mittendorf EA, Yi M, Hunt KK et al (2017) Outcomes of sentinel lymph node-positive breast cancer patients treated with mastectomy without axillary therapy. Ann Surg Oncol 24(3):652\u2013659","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"4840_CR22","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1245\/s10434-012-2386-3","volume":"19","author":"S Milgrom","year":"2012","unstructured":"Milgrom S, Cody H, Tan L, Morrow M, Pesce C, Setton J et al (2012) Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment. Ann Surg Oncol 19(12):3762\u20133770","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"4840_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.amjsurg.2015.05.004","volume":"210","author":"R Snow","year":"2015","unstructured":"Snow R, Reyna C, Johns C, Lee MC, Sun W, Fulp WJ et al (2015) Outcomes with and without axillary node dissection for node-positive lumpectomy and mastectomy patients. Am J Surg 210(4):685\u2013693","journal-title":"Am J Surg"},{"issue":"8","key":"4840_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347(8):567\u2013575","journal-title":"N Engl J Med"},{"issue":"2","key":"4840_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10549-015-3549-2","volume":"153","author":"DP Joyce","year":"2015","unstructured":"Joyce DP, Manning A, Carter M, Hill AD, Kell MR, Barry M (2015) Meta-analysis to determine the clinical impact of axillary lymph node dissection in the treatment of invasive breast cancer. Breast Cancer Res Treat 153(2):235\u2013240","journal-title":"Breast Cancer Res Treat"},{"key":"4840_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejca.2016.08.003","volume":"67","author":"G Houvenaeghel","year":"2016","unstructured":"Houvenaeghel G, Boher JM, Reyal F, Cohen M, Garbay JR, Classe JM et al (2016) Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes. Eur J Cancer 67:106\u2013118","journal-title":"Eur J Cancer"},{"issue":"8","key":"4840_CR27","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/cncr.24174","volume":"115","author":"M Sanghani","year":"2009","unstructured":"Sanghani M, Balk EM, Cady B (2009) Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis. Cancer 115(8):1613\u20131620","journal-title":"Cancer"},{"issue":"1","key":"4840_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","volume":"17","author":"J Boniface de","year":"2017","unstructured":"de Boniface J, Frisell J, Andersson Y, Bergkvist L, Ahlgren J, Ryden L et al (2017) Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial. BMC Cancer 17(1):379","journal-title":"BMC Cancer"},{"key":"4840_CR29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s12885-015-1613-2","volume":"15","author":"LM Roozendaal van","year":"2015","unstructured":"van Roozendaal LM, de Wilt JH, van Dalen T, van der Hage JA, Strobbe LJ, Boersma LJ et al (2015) The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07). BMC Cancer 15:610","journal-title":"BMC Cancer"},{"issue":"4","key":"4840_CR30","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","volume":"43","author":"A Savolt","year":"2017","unstructured":"Savolt A, Peley G, Polgar C, Udvarhelyi N, Rubovszky G, Kovacs E et al (2017) Eight-year follow up result of the OTOASOR trial: the Optimal treatment of the axilla\u2014surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol 43(4):672\u2013679","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"4840_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","volume":"20","author":"M Sola","year":"2013","unstructured":"Sola M, Alberro JA, Fraile M, Santesteban P, Ramos M, Fabregas R et al (2013) Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000. Ann Surg Oncol 20(1):120\u2013127","journal-title":"Ann Surg Oncol"},{"key":"4840_CR32","doi-asserted-by":"crossref","unstructured":"Galimberti V, Cole BF, viale G, veronesi P, Vicini E, Intra M et al (2017) Axillary dissection vs. no axillary dissection in patients with cT1-T2cN0M0 breast cancer and only micrometastases in the sentinel node(s): ten-year results of the IBCSG 23-01 Trial. San Antonio Breast Cancer Symposium","DOI":"10.1158\/1538-7445.SABCS17-GS5-02"},{"issue":"2","key":"4840_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/jnci\/djh297","volume":"97","author":"J Ragaz","year":"2005","unstructured":"Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS et al (2005) Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97(2):116\u2013126","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"4840_CR34","doi-asserted-by":"publisher","first-page":"247253","DOI":"10.1016\/j.radonc.2007.02.001","volume":"82","author":"M Overgaard","year":"2007","unstructured":"Overgaard M, Nielsen HM, Overgaard J (2007) Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol. 82(3):247\u2013253","journal-title":"Radiother Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-4840-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4840-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4840-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T08:16:59Z","timestamp":1720340219000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-4840-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4840"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-4840-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"23 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study utilizes retrospective, de-identified information. Informed consent was not necessary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}]}}